Short-term effects of ocrelizumab on cortical pathology in patients with multiple sclerosis
{{output}}
Cortical lesions (CLs) are a common finding in multiple sclerosis (MS) but data regarding the impact of treatment on their evolution are lacking. This study evaluates CLs status and new CLs accrual over two-year follow-up in a cohort of patients treated with o... ...
